Selank is a nootropic, anxiolytic peptide based drug developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. Selank is a somewhat mysterious peptide whose mechanism of action is not yet fully elucidated, despite the ample evidence collected so far that supports its unique clinical and preclinical efficacy. Selank is a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is a synthetic analogue of human tuftsin.
The benefits of Selank can be divided into the following categories:
Reinforcement of the body’s protective opioid system
Therapy of generalized anxiety and neurasthenia (ie. abnormal weakness)
Enhancement of learning and memory
Strengthens antiviral immune function
Protects against alcohol-induced memory impairment
Improves symptoms associated with alcohol withdrawal
***RESEARCH USE ONLY***
*The information herein is for educational and informational purposes only. THIS PRODUCT IS FOR RESEARCH USE ONLY. For use in animal studies, all research must be conducted with oversight from the appropriate Institutional Animal Care and Use Committee (IACUC) following the guidelines of the Animal Welfare Act (AWA).